Lumiata, a US-based provider of medical science analytics, has closed a $10m series A round funded by investors including BlueCross BlueShield Venture Partners, the corporate venturing arm of healthcare consortium BlueCross BlueShield.
Lumiata, which was founded last year, initially raised $4m in January from venture capital firm Khosla Ventures, before securing a further $6m from BlueCross BlueShield and its long term partner Sandbox Industries.
The company is developing a predictive big data-based analysis system that can supply real-time hyper-personalised analytics at scale through a detailed graph. It is currently engaging with major hospital networks, healthcare providers and health insurance companies to harness information on patient risk.